Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Oncoimmunology|November 19, 2013
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?David Escors, Therese Liechtenstein, Noemi Perez-Janices, et al.
Clinical Epigenetics|February 3, 2017
<i>CDH22</i> hypermethylation is an independent prognostic biomarker in breast cancerEsperanza Martín-Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, et al.
International Journal of Molecular Sciences|March 25, 2020
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the CervixSaioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, et al.
Clinical Epigenetics|December 14, 2023
ZEB1 hypermethylation is associated with better prognosis in patients with colon cancerIrene Fernandez-De-Los-Reyes, Marisa Gomez-Dorronsoro, Iñaki Monreal-Santesteban, et al.
Virchows Archiv : an International Journal of Pathology|February 23, 2024
Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomasLuiz M Nova-Camacho, Andres M Acosta, Mahmut Akgul, et al.
Virus Research|June 4, 2013
Immune modulation by genetic modification of dendritic cells with lentiviral vectorsTherese Liechtenstein, Noemi Perez-Janices, Christopher Bricogne, et al.
Pageof 3